1. |
Cheung N, Mitchell P, Wong TY. Diabetic retinopathy[J]. Lancet, 2010, 376(9735): 124-136. DOI: 10.1016/S0140-6736(09)62124-3.
|
2. |
Juliusson G, Hough R. Leukemia[J]. Prog Tumor Res, 2016, 43: 87-100. DOI: 10.1159/000447076.
|
3. |
Apperley JF. Chronic myeloid leukaemia[J]. Lancet, 2015, 385(9976): 1447-1459. DOI: 10.1016/S0140-6736(13)62120-0.
|
4. |
Reddy SC, Jackson N, Menon BS. Ocular involvement in leukemia--a study of 288 cases[J]. Ophthalmologica, 2003, 217(6): 441-445. DOI: 10.1159/000073077.
|
5. |
Guyer DR, Schachat AP, Vitale S, et al. Leukemic retinopathy. relationship between fundus lesions and hematologic parameters at diagnosis[J]. Ophthalmology, 1989, 96(6): 860-864. DOI: 10.1016/s0161-6420(89)32809-0.
|
6. |
Rosenthal AR. Ocular manifestations of leukemia: a review[J]. Ophthalmology, 1983, 90(8): 899-905. DOI: 10.1016/s0161-6420(83)80013-x.
|
7. |
Nobacht S, Vandoninck KF, Deutman AF, et al. Peripheral retinal nonperfusion associated with chronic myeloid leukemia[J]. Am J Ophthalmol, 2003, 135(3): 404-406. DOI: 10.1016/s0002-9394(02)01956-6.
|
8. |
Frank RN, Ryan SJ Jr. Peripheral retinal neovascularization with chronic myelogenous leukemia[J]. Arch Ophthalmol, 1972, 87(5): 585-589. DOI: 10.1001/archopht.1972.01000020587017.
|
9. |
Hoerauf H, Bopp S, Laqua H. Proliferative retinopathy in chronic myeloid leukemia[J]. Klin Monbl Augenheilkd, 1994, 205(4): 226-130. DOI: 10.1055/s-2008-1045520.
|
10. |
Hasanreisoglu B, Or M, Atmaca LS, et al. Pars plana vitrectomy in chronic myelogenous leukemia with vitreous hemorrhage[J]. Jpn J Ophthalmol, 1988, 32(3): 304-309.
|
11. |
Mandava N, Costakos D, Bartlett HM. Chronic myelogenous leukemia manifested as bilateral proliferative retinopathy[J]. Arch Ophthalmol, 2005, 123(4): 576-577. DOI: 10.1001/archopht.123.4.576.
|
12. |
Yoshid F, Okamoto N, Hosotani Y, et al. A case of acute lymphoblastic leukemia with variable appearance[J]. Nippon Ganka Gakkai Zasshi, 2010, 114(1): 28-33.
|
13. |
Chawla R, Kumar S, Kumawat D, et al. Chronic myeloid leukaemia accelerates proliferative retinopathy in patients with co-existent diabetes: a risk factor not to be ignored[J/OL]. Eur J Ophthalmol, 2019, 2019: 1120672119875341[2019-09-12].https://pubmed.ncbi.nlm.nih.gov/31514533/. DOI: 10.1177/1120672119875341.
|
14. |
居钰乔, 杨茜, 常青, 等. 合并慢性粒细胞白血病的增生型糖尿病视网膜病变患者五例[J]. 中华眼底病杂志, 2021, 37(1): ……. DOI: 10.3760/cma.j.cn511434-20201223-00632.Ju YQ, Yang Q, Chang Q, et al. Clinical observations of proliferative diabetic retinopathy with chronic myeloid leukemia of five cases[J]. Chin J Ocul Fundus Dis, 2021, 37(1): ……. DOI: 10.3760/cma.j.cn511434-20201223-00632.
|
15. |
Figueiredo LM, Rothwell RT, Meira D, et al. Chronic myeloid leukemia diagnosed in a patient with uncontrolled proliferative diabetic retinopathy[J]. Retin Cases Brief Rep, 2015, 9(3): 210-213. DOI: 10.1097/ICB.0000000000000140.
|
16. |
Tsiamita O, Siempis T, Varikkara M. Reduced vision in a diabetic patient due to incidental leukaemic retinopathy[J]. Clin Exp Optom, 2019, 102(1): 91-93. DOI: 10.1111/cxo.12808.
|
17. |
Shahid SM, Waqar S, Ling R. Sudden apparent worsening of diabetic retinopathy leading to a diagnosis of chronic myeloid leukaemia[J/OL]. Br J Hosp Med (Lond), 2013, 74(9): 533[2013-11-13]. https://pubmed.ncbi.nlm.nih.gov/24022560/. DOI: 10.12968/hmed.2013.74.9.533.
|
18. |
Rocke JR, Clark JB, Campbell PJ, et al. Florid Neovascularization of the retina in a diabetic patient undergoing induction and consolidation therapy for acute promyelocytic leukemia[J]. Retin Cases Brief Rep, 2019, 13(2): 189-193. DOI: 10.1097/ICB.0000000000000560.
|
19. |
Roop P, Angmo D, Kamble N, et al. Uncontrolled neovascular glaucoma-an alarming manifestation of chronic myeloid leukemia on imatinib therapy-a case report and review of literature[J]. Indian J Ophthalmol, 2019, 67(2): 285-287. DOI: 10.4103/ijo.IJO_1288_18.
|
20. |
Melberg NS, Grand MG, Rup D. The impact of acute lymphocytic leukemia on diabetic retinopathy[J]. J Pediatr Hematol Oncol, 1995, 17(1): 81-84. DOI: 10.1097/00043426-199502000-00015.
|
21. |
Holt JM, Gordon-Smith EC. Retinal abnormalities in diseases of the blood[J]. Br J Ophthalmol, 1969, 53(3): 145-160. DOI: 10.1136/bjo.53.3.145.
|
22. |
Viswanath K, McGavin DD. Diabetic retinopathy: clinical findings and management[J]. Community Eye Health, 2003, 16(46): 21-24.
|
23. |
Luxenberg MN, Mausolf FA. Retinal circulation in the hyperviscosity syndrome[J]. Am J Ophthalmol, 1970, 70(4): 588-598. DOI: 10.1016/0002-9394(70)90894-9.
|
24. |
Merin S, Freund M. Retinopathy in severe anemia[J]. Am J Ophthalmol, 1968, 66(6): 1102-1106. DOI: 10.1016/0002-9394(68)90818-0.
|
25. |
Kincaid MC, Green WR. Ocular and orbital involvement in leukemia[J]. Surv Ophthalmol, 1983, 27(4): 211-232. DOI: 10.1016/0039-6257(83)90123-6.
|
26. |
Malek R, Davis SN. Tyrosine kinase inhibitors under investigation for the treatment of type Ⅱ diabetes[J]. Expert Opin Investig Drugs, 2016, 25(3): 287-296. DOI: 10.1517/13543784.2016.1142531.
|
27. |
Martino B, Mammi C, Labate C, et al. Genetic risk of prediabetes and diabetes development in chronic myeloid leukemia patients treated with nilotinib[J]. Exp Hematol, 2017, 55: 71-75. DOI: 10.1016/j.exphem.2017.07.007.
|
28. |
Prada PO, Saad MJ. Tyrosine kinase inhibitors as novel drugs for the treatment of diabetes[J]. Expert Opin Investig Drugs, 2013, 22(6): 751-763. DOI: 10.1517/13543784.2013.802768.
|
29. |
Porges Y, Blumen S, Fireman Z, et al. Cyclosporine-induced optic neuropathy, ophthalmoplegia, and nystagmus in a patient with Crohn disease[J]. Am J Ophthalmol, 1998, 126(4): 607-609. DOI: 10.1016/s0002-9394(98)00137-8.
|
30. |
Zamber RW, Kinyoun JL. Radiation retinopathy[J]. West J Med, 1992, 157(5): 530-533.
|
31. |
Sillaber C, Mayerhofer M, Aichberger KJ, et al. Expression of angiogenic factors in chronic myeloid leukaemia: role of the bcr/abl oncogene, biochemical mechanisms, and potential clinical implications[J]. Eur J Clin Invest, 2004, 34 Suppl 2: S2-11. DOI: 10.1111/j.0960-135X.2004.01365.x.
|
32. |
Schmid S, Lang-Muritano M, Meier U, et al. Transient severe non-proliferative retinopathy in an adolescent with type 1 diabetes and chronic myeloid leukemia[J]. Pediatr Diabetes, 2013, 14(3): 227-229. DOI: 10.1111/j.1399-5448.2012.00901.x.
|
33. |
Bhisitkul RB. Vascular endothelial growth factor biology: clinical implications for ocular treatments[J]. Br J Ophthalmol, 2006, 90(12): 1542-1547. DOI: 10.1136/bjo.2006.098426.
|